「and a」の検索結果
112件：51～55件目を表示
-
お知らせ | 千寿製薬株式会社
June 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（...
http://www.senju.co.jp/english/news/ -
grapher equipped with Auto Refract Keratometer, Topographer, Wavefront, Dry eye analysis (optional) and Meibomian glands analysis, as the device is all in one with functionality and operability. This ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
f Phase III clinical trials in Japan, which consisted of the comparative (placebo-controlled) trial and the long-term administration trial. During the comparative trial, the primary efficacy endpoints...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
grapher equipped with Auto Refract Keratometer, Topographer, Wavefront, Dry eye analysis (optional) and Meibomian glands analysis, as the device is all in one with functionality and operability. This ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf -
Production | About Senju | SENJU Pharmaceutical
Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject...
https://www.senju.co.jp/english/about/production.html